Shaping the Future of Cardiac Wellness: Exploring Revolutionary Approaches in Disease Management and Prevention

Abstract

Cardiovascular diseases (CVDs) remain a leading cause of morbidity and mortality worldwide. Effective prevention and management strategies are essential to reduce the burden of CVDs. This review summarizes recent advances in the prevention and management of CVDs. In terms of prevention, lifestyle modifications, such as diet, exercise, and smoking cessation, remain important strategies. Pharmacological interventions, including statins, antiplatelet agents, and antihypertensive medications, have also shown benefits. Innovative approaches, such as genetic testing and risk stratification, targeted prevention strategies, and the use of mobile health technology, are being explored. In terms of management, acute management strategies, such as reperfusion therapy for myocardial infarction, acute heart failure management, and stroke management, have improved outcomes. Chronic management strategies, including medical therapy for heart failure, arrhythmia management, and device therapy for heart failure, have also shown benefits. Innovative approaches, such as precision medicine and personalized treatment, the use of artificial intelligence in diagnosis and treatment, and advances in traditional Chinese and regenerative medicine, are being investigated. While recent advances in the prevention and management of CVDs are promising, challenges remain in implementing these strategies, including cost-effectiveness, access to care, and resistance to change in clinical practice. Continued research and innovation are essential to reduce the burden of CVDs and improve patient outcomes.

Transforming Screening, Risk Stratification, and Treatment Optimization in Chronic Liver Disease Through Data Science and translational Innovation

“…G6PD deficiency impairs response to oxidative stress, raising concerns about transplantation suitability. [42][43][44][45] However, recent cohorts adjusting for confounders showed no impact of G6PD status on recipient survival. Though G6PD deficiency may still increase risks of dysfunction or non-anastomotic biliary strictures, with close monitoring it need not preclude donation.…”

Machine Learning Approach towards Quality Assurance, Challenges and Possible Strategies in Laboratory Medicine

“…11 The expansion of automation in the sample collections & testing methods, smartphone health-related applications and software, reporting, and record-keeping systems has been suggested and implemented to manage chronic diseases. 12 Interventions in laboratory medicine have contributed to improved disease control patterns. 13 Patient empowerment is a second major trend relevant to this automation loop in the sense of patient empowerment.…”